Medizinische Universitaet Innsbruck ( Site 0301)

Innsbruck, Tyrol 6020

1 studies enrolling now · 2 studies all time

What they study most

Cervical Cancer, Pneumococcal Disease

Studies at this site

• A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) — Recruiting now
• A Study to Evaluate the Safety, Tolerability, Immunogenicity, and Lot Consistency of V116 in Adults 18 to 49 Years of Age (V116-004, STRIDE-4) — Completed